Provided by Tiger Trade Technology Pte. Ltd.

BEONE MEDICINES

215.400
-9.000-4.01%
Volume:5.34M
Turnover:1.15B
Market Cap:332.15B
PE:144.63
High:219.400
Open:215.000
Low:212.200
Close:224.400
52wk High:235.600
52wk Low:153.000
Shares:1.54B
HK Float Shares:1.43B
Volume Ratio:1.75
T/O Rate:0.37%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.489
ROE:14.66%
ROA:7.46%
PB:8.19
PE(LYR):144.63
PS:6.91

Loading ...

BeiGene Invests Additional $300 Million in US Expansion, Stock Hits 3-Month High; Hong Kong Stock Connect Innovative Drugs Show Local Strength, 520880 Rises for Third Consecutive Day Against Market

Deep News
·
Jul 24

Movement Alert|BEIGENE Rises 4.13% in Regular Trading, Adds $300 Million Investment to Expand US Manufacturing

Market Focus
·
Jul 24

Amgen and BeiGene Advance Subcutaneous Formulation of FIC Bispecific Antibody into Phase III Trial

Deep News
·
Jul 23

Movement Alert|BeOne Medicines Rises 3.39% in Regular Trading, Trading at HK$192.7

Market Focus
·
Jul 20

Movement Alert|BeiGene Falls 3.04% in Regular Trading, Trading at HKD 185.5

Market Focus
·
Jul 17

Movement Alert|BeOne Medicines Rises 3.23% in Regular Trading, Biotech Sector Rallies on Policy Tailwinds from National Essential Drug List Update

Market Focus
·
Jul 15

Movement Alert|BeOne Medicines Rises 3.19% in Regular Trading, Brukinsa MANGROVE Phase 3 Data and New Buy Rating Drive Momentum

Market Focus
·
Jul 10

BeiGene grants 33,388 ADS-linked RSUs to 215 employees, equal to 0.03% of share capital

Bulletin Express
·
Jul 08

BEIGENE Awards Aggregate 33,400 Restricted Stock Units Represented by American Depositary Shares

Stock News
·
Jul 08

BeOne Medicines — June 2026 Share Capital Steady; Option Grants Lift Potential Dilution, Public Float Intact

Bulletin Express
·
Jul 08

Movement Alert|BeOne Medicines Declines 3.1% in Regular Trading, Trading at HK$184.3

Market Focus
·
Jul 07

Movement Alert|BeOne Medicines Rises 3.17% in Regular Trading, Brukinsa Phase 3 MANGROVE Trial Positive Data Continues to Catalyze

Market Focus
·
Jul 06

Movement Alert|BeiGene Rises 3.49% in Regular Trading, Brukinsa Phase 3 Positive Data and Insurance Policy Catalysts Sustain Momentum

Market Focus
·
Jul 03

BEIGENE Shares Surge Over 4% on Positive Phase 3 Clinical Trial News for Zanubrutinib

Stock News
·
Jul 03

Movement Alert|BeOne Medicines Rises 3.35% in Regular Trading, Brukinsa Phase 3 Positive Data and Sector Rally Lift Shares

Market Focus
·
Jul 02

Market Insights: US Inflation Remains Elevated; Southbound Stock Connect Threshold May Have Risen to HKD 10.267 Billion

Stock News
·
Jul 02

BeOne Medicines' Brukinsa Shows 43% Risk Reduction in Mantle Cell Lymphoma Trial; Shares Down 3%

MT Newswires Live
·
Jul 01

BEIGENE Reports Positive Phase 3 Trial Results for BRUKINSA® in First-Line Treatment of Mantle Cell Lymphoma

Stock News
·
Jun 30

Movement Alert|BeOne Medicines Falls 3.21% in Regular Trading, Biotech Sector Collective Pullback Compounds Tax Payment Overhang

Market Focus
·
Jun 30

Movement Alert|BeOne Medicines Rises 3.01% in Regular Trading, Rebounding After Tax Payment Overhang Digested

Market Focus
·
Jun 29